GlassScriptPhysician profile
Kara Choate
NPI 1033505995
$16,311.74
in general payments reported to CMS, 2019-2025
42 companies · $2,690 in 2025
The $2,690 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $901 · 2021: $5,478 · 2022: $2,824 · 2023: $3,104 · 2024: $1,313 · 2025: $2,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,226 · Consulting Fee: $1,420 · Travel and Lodging: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,225.79 |
| Consulting Fee | $1,420.00 |
| Travel and Lodging | $461.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,093.01 | 2021-2025 | Interstim, Nuro, Altaviva |
| Coloplast Corp | $2,860.26 | 2021-2023 | Altis, Speedicath |
| Boston Scientific Corporation | $946.94 | 2020-2025 | Spaceoar Vue System - 10ml, Lithovue |
| Axonics, INC. | $870.20 | 2021-2024 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $405.61 | 2021-2025 | Jelmyto |
| Abbvie INC. | $395.99 | 2021-2024 | Botox, Lupron Depot |
| Astellas Pharma US INC | $313.58 | 2021-2024 | Myrbetriq |
| Teleflex LLC | $297.07 | 2021-2025 | Barrigel |
| Sumitomo Pharma America, INC. | $285.28 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $283.04 | 2022-2025 | Erleada, Akeega |
| Baxter Healthcare | $230.34 | 2020 | |
| Endo Pharmaceuticals INC. | $179.53 | 2020-2021 | |
| Amgen INC. | $177.67 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $168.71 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $126.47 | 2024-2025 | Adstiladrin |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Choate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.